Evi1 is essential for hematopoietic stem cell self-renewal, and its expression marks hematopoietic cells with long-term multilineage repopulating activity

Journal of Experimental Medicine

Volumn 208, Issue 12, 2011, Pages 2403-2416

  Kataoka, Keisuke ^a   Sato, Tomohiko ^a   Yoshimi, Akihide ^a   Goyama, Susumu ^a   Tsuruta, Takako ^a   Kobayashi, Hiroshi ^a   Shimabe, Munetake ^a   Arai, Shunya ^a   Nakagawa, Masahiro ^a   Imai, Yoichi ^a   Kumano, Keiki ^a   Kumagai, Katsuyoshi ^b   Kubota, Naoto ^b   Kadowaki, Takashi ^b   Kurokawa, Mineo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EVI1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL LINEAGE; CELL RENEWAL; HEMATOPOIETIC STEM CELL; INTERNAL RIBOSOME ENTRY SITE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; DNA PRIMERS; DNA-BINDING PROTEINS; EMBRYO, MAMMALIAN; FEMALE; FLOW CYTOMETRY; GENE KNOCK-IN TECHNIQUES; GENOTYPE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; LIVER; MESONEPHROS; MICE; PLACENTA; PREGNANCY; PROTO-ONCOGENES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 84862908988     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20110447     Document Type: Article

References (33)

1. Akashi, K., X. He, J. Chen, H. Iwasaki, C. Niu, B. Steenhard, J. Zhang, J. Haug, and L. Li. 2003. Transcriptional accessibility for genes of multiple tissues and hematopoietic lineages is hierarchically controlled during early hematopoiesis. Blood. 101:383-389. http://dx.doi.org/10.1182/blood-2002-06-1780
2. Bowie, M.B., K.D. McKnight, D.G. Kent, L. McCaffrey, P.A. Hoodless, and C.J. Eaves. 2006. Hematopoietic stem cells proliferate until after birth and show a reversible phase-specific engraftment defect. J. Clin. Invest. 116:2808-2816. http://dx.doi.org/10.1172/JCI28310
3. Buonamici, S., D. Li, Y. Chi, R. Zhao, X. Wang, L. Brace, H. Ni, Y. Saunthararajah, and G. Nucifora. 2004. EVI1 induces myelodysplastic syndrome in mice. J. Clin. Invest. 114:713-719.
4. Chen, W., A.R. Kumar, W.A. Hudson, Q. Li, B. Wu, R.A. Staggs, E.A. Lund, T.N. Sam, and J.H. Kersey. 2008. Malignant transformation initiated by Mll-AF9: gene dosage and critical target cells. Cancer Cell. 13:432-440. http://dx.doi.org/10.1016/j.ccr.2008.03.005
5. Forsberg, E.C., E. Passegué, S.S. Prohaska, A.J. Wagers, M. Koeva, J.M. Stuart, and I.L. Weissman. 2010. Molecular signatures of quiescent, mobilized and leukemia-initiating hematopoietic stem cells. PLoS ONE. 5:e8785. http://dx.doi.org/10.1371/journal.pone.0008785
6. Fröhling, S., C. Scholl, D.G. Gilliland, and R.L. Levine. 2005. Genetics of myeloid malignancies: pathogenetic and clinical implications. J. Clin. Oncol. 23:6285-6295. http://dx.doi.org/10.1200/JCO.2005.05.010
7. Goyama, S., and M. Kurokawa. 2009. Pathogenetic significance of ecotropic viral integration site-1 in hematological malignancies. Cancer Sci. 100:990-995. http://dx.doi.org/10.1111/j.1349-7006.2009.01152.x
8. Goyama, S., G. Yamamoto, M. Shimabe, T. Sato, M. Ichikawa, S. Ogawa, S. Chiba, and M. Kurokawa. 2008. Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells. Cell Stem Cell. 3:207-220. http://dx.doi.org/10.1016/j.stem.2008.06.002
9. Grassinger, J., D.N. Haylock, B. Williams, G.H. Olsen, and S.K. Nilsson. 2010. Phenotypically identical hemopoietic stem cells isolated from different regions of bone marrow have different biologic potential. Blood. 116:3185-3196. http://dx.doi.org/10.1182/blood-2009-12-260703
10. Gröschel, S., S. Lugthart, R.F. Schlenk, P.J. Valk, K. Eiwen, C. Goudswaard, W.J. van Putten, S. Kayser, L.F. Verdonck, M. Lübbert, et al. 2010. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities. J. Clin. Oncol. 28:2101-2107. http://dx.doi.org/10.1200/JCO.2009.26.0646
11. Kiel, M.J., O.H. Yilmaz, T. Iwashita, O.H. Yilmaz, C. Terhorst, and S.J. Morrison. 2005. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell. 121:1109-1121. http://dx.doi.org/10.1016/j.cell.2005.05.026
12. Kim, I., S. He, O.H. Yilmaz, M.J. Kiel, and S.J. Morrison. 2006. Enhanced purification of fetal liver hematopoietic stem cells using SLAM family receptors. Blood. 108:737-744. http://dx.doi.org/10.1182/ blood-2005-10-4135
13. Kurokawa, M., K. Mitani, K. Irie, T. Matsuyama, T. Takahashi, S. Chiba, Y. Yazaki, K. Matsumoto, and H. Hirai. 1998. The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3. Nature. 394:92-96. http://dx.doi.org/10.1038/27945
14. Lugthart, S., E. van Drunen, Y. van Norden, A. van Hoven, C.A. Erpelinck, P.J. Valk, H.B. Beverloo, B. Löwenberg, and R. Delwel. 2008. High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated. Blood. 111:4329-4337. http://dx.doi.org/10.1182/blood-2007-10-119230
15. Lugthart, S., S. Gröschel, H.B. Beverloo, S. Kayser, P.J. Valk, S.L. van Zelderen-Bhola, G. Jan Ossenkoppele, E. Vellenga, E. van den Bergde Ruiter, U. Schanz, et al. 2010. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia. J. Clin. Oncol. 28:3890-3898. http://dx.doi.org/10.1200/JCO.2010.29.2771
16. McKinney-Freeman, S.L., O. Naveiras, F. Yates, S. Loewer, M. Philitas, M. Curran, P.J. Park, and G.Q. Daley. 2009. Surface antigen phenotypes of hematopoietic stem cells from embryos and murine embryonic stem cells. Blood. 114:268-278. http://dx.doi.org/10.1182/blood-2008-12-193888
17. Mikkola, H.K., and S.H. Orkin. 2006. The journey of developing hematopoietic stem cells. Development. 133:3733-3744. http://dx.doi
18. Morikawa, S., Y. Mabuchi, Y. Kubota, Y. Nagai, K. Niibe, E. Hiratsu, S. Suzuki, C. Miyauchi-Hara, N. Nagoshi, T. Sunabori, et al. 2009. Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J. Exp. Med. 206:2483-2496. http://dx.doi.org/10.1084/jem.20091046.org/10.1242/dev.02568
19. Morishita, K., E. Parganas, D.M. Parham, T. Matsugi, and J.N. Ihle. 1990. The Evi-1 zinc finger myeloid transforming gene is normally expressed in the kidney and in developing oocytes. Oncogene. 5:1419-1423.
20. Nakamura, Y., F. Arai, H. Iwasaki, K. Hosokawa, I. Kobayashi, Y. Gomei, Y. Matsumoto, H. Yoshihara, and T. Suda. 2010. Isolation and characterization of endosteal niche cell populations that regulate hematopoietic stem cells. Blood. 116:1422-1432. http://dx.doi.org/10.1182/ blood-2009-08-239194
21. Orford, K.W., and D.T. Scadden. 2008. Deconstructing stem cell selfrenewal: genetic insights into cell-cycle regulation. Nat. Rev. Genet. 9:115-128. http://dx.doi.org/10.1038/nrg2269
22. Orkin, S.H., and L.I. Zon. 2008. Hematopoiesis: an evolving paradigm for stem cell biology. Cell. 132:631-644. http://dx.doi.org/10.1016/j.cell.2008.01.025
23. Perkins, A.S., J.A. Mercer, N.A. Jenkins, and N.G. Copeland. 1991. Patterns of Evi-1 expression in embryonic and adult tissues suggest that Evi-1 plays an important regulatory role in mouse development. Development. 111:479-487.
24. Ramalho-Santos, M., S. Yoon, Y. Matsuzaki, R.C. Mulligan, and D.A. Melton. 2002. "Stemness": transcriptional profiling of embryonic and adult stem cells. Science. 298:597-600. http://dx.doi.org/10.1126/science.1072530
25. Sato, T., S. Goyama, E. Nitta, M. Takeshita, M. Yoshimi, M. Nakagawa, M. Kawazu, M. Ichikawa, and M. Kurokawa. 2008. Evi-1 promotes para-aortic splanchnopleural hematopoiesis through up-regulation of GATA-2 and repression of TGF-b signaling. Cancer Sci. 99:1407-1413. http://dx.doi.org/10.1111/j.1349-7006.2008.00842.x
26. Senyuk, V., K.K. Sinha, D. Li, C.R. Rinaldi, S. Yanamandra, and G. Nucifora. 2007. Repression of RUNX1 activity by EVI1: a new role of EVI1 in leukemogenesis. Cancer Res. 67:5658-5666. http://dx.doi.org/10.1158/0008-5472.CAN-06-3962
27. Shimabe, M., S. Goyama, N. Watanabe-Okochi, A. Yoshimi, M. Ichikawa, Y. Imai, and M. Kurokawa. 2009. Pbx1 is a downstream target of Evi- 1 in hematopoietic stem/progenitors and leukemic cells. Oncogene. 28:4364-4374. http://dx.doi.org/10.1038/onc.2009.288
28. Stein, S., M.G. Ott, S. Schultze-Strasser, A. Jauch, B. Burwinkel, A. Kinner, M. Schmidt, A. Krämer, J. Schwäble, H. Glimm, et al. 2010. Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat. Med. 16:198-204. http://dx.doi.org/10.1038/nm.2088
29. Su, A.I., T. Wiltshire, S. Batalov, H. Lapp, K.A. Ching, D. Block, J. Zhang, R. Soden, M. Hayakawa, G. Kreiman, et al. 2004. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. USA. 101:6062-6067. http://dx.doi.org/10.1073/pnas.0400782101
30. Takakura, N., T. Watanabe, S. Suenobu, Y. Yamada, T. Noda, Y. Ito, M. Satake, and T. Suda. 2000. A role for hematopoietic stem cells in promoting angiogenesis. Cell. 102:199-209. http://dx.doi.org/10.1016/ S0092-8674(00)00025-8
31. Weksberg, D.C., S.M. Chambers, N.C. Boles, and M.A. Goodell. 2008. CD150- side population cells represent a functionally distinct population of long-term hematopoietic stem cells. Blood. 111:2444-2451. http://dx.doi.org/10.1182/blood-2007-09-115006
32. Yuasa, H., Y. Oike, A. Iwama, I. Nishikata, D. Sugiyama, A. Perkins, M.L. Mucenski, T. Suda, and K. Morishita. 2005. Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression. EMBO J. 24:1976-1987. http://dx.doi.org/10.1038/sj.emboj.7600679
33. Zhang, Y., S. Stehling-Sun, K. Lezon-Geyda, S.C. Juneja, L. Coillard, G. Chatterjee, C.A. Wuertzer, F. Camargo, and A.S. Perkins. 2011. PR domain-containing Mds1-Evi1 is critical for long-term hematopoietic stem cells function. Blood. 118:3856-3861.